GLNT gets another patent to treat Parkinson’s for transcranial direct current stimulation during sleep

Great Lakes NeuroTechnologies, a Cleveland-area company that promised more focus on DBS treatments as well as new products this year, has expanded its intellectual property in that area
 The patent covers a wearable apparatus that positions an array of electrodes on the surface of the scalp and provides low-dose stimulation to the brain using transcranial direct current stimulation (tDCS) during different stages of sleep.

“While current approaches aim to target the location of stimulation to the brain, this approach is targeting the timing of stimulation by delivering it during sleep,” said Dustin Heldman, principal investigator and biomedical research manager.

Because the device method works while the patient is sleeping, it should limit patient discomfort while maybe targeting brain states likely to improve motor symptoms, according to the company.

The phase 1 clinical study for this method is ongoing.

Brian Kolkowski, EVP and general counsel at GLNT, said a growing patent portfolio that protects technology in the company’s targeted markets provides a strategic advantage.

Movement disorders, especially Parkinson’s, have been a large focus of GLNT, which also deals with telehealth and physiological monitoring for research and education.

Read more: http://medcitynews.com/2013/07/glnt-receives-another-patent-to-treat-parkinsons-this-time-for-deep-brain-stimulating-method-delivered-while-patient-snoozes/#ixzz2zLylIRYM